| Application no. and date | 15707351.1 (espacenet) (Federated) (European Patent Register), 20150227 | | Patent/reg. no. and date | DK/EP 3110442, 20201014 | | Publication date | 20170104 | | Priority no. and date | EP 14157399, 20140228, EP 14177566, 20140717 | | EP pub. no. and date |
EP 3110442 20170104 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals SA, Rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | 164238 | | Inventor | Scarselli, Maria, Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena, IT,
BOTTOMLEY, Matthew, Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena, IT,
MALITO, Enrico, Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena, IT,
MARTINELLI, Manuele, Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena, IT | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/095 (2006.01) , C07K 14/095 (2006.01) , C07K 14/22 (2006.01) | | Title | MODIFICEREDE MENINGOKOK-FHBP-POLYPEPTIDER | | Int. application no. | EP2015054174 | | Int. publication no. | WO2015128480 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
